Abstract:BACKGROUND & AIMS: <AbstractText Label="BACKGROUND &amp; AIMS">Although the role of gut microbiota in Clostridioides difficile infection (CDI) has been well established, little is known about the role of mycobiota in CDI. Here, we performed mycobiome data analysis in a well-characterized human cohort to evaluate the potential of using gut mycobiota features for CDI diagnosis.</AbstractText>METHODS: <AbstractText Label="METHODS">Stool samples were collected from 118 hospital patients, divided into 3 groups: CDI (n = 58), asymptomatic carriers (Carrier, n = 28), and Control (n = 32). The nuclear ribosomal DNA internal transcribed spacer 2 was sequenced using the Illumina HiSeq platform to assess the fungal composition. Downstream statistical analyses (including Alpha diversity analysis, ordination analysis, differential abundance analysis, fungal correlation network analysis, and classification analysis) were then performed.</AbstractText>RESULTS: <AbstractText Label="RESULTS">Significant differences were observed in alpha and beta diversity between patients with CDI and Carrier (P &lt; .05). Differential abundance analysis identified 2 genera (Cladosporium and Aspergillus) enriched in Carrier. The ratio of Ascomycota to Basidiomycota was dramatically higher in patients with CDI than in Carrier and Control (P &lt; .05). Correlations between host immune factors and mycobiota features were weaker in patients with CDI than in Carrier. Using 4 fungal operational taxonomic units combined with 6 host immune markers in the random forest classifier can achieve very high performance (area under the curve ∼92.38%) in distinguishing patients with CDI from Carrier.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS">Our study provides specific markers of stool fungi combined with host immune factors to distinguish patients with CDI from Carrier. It highlights the importance of gut mycobiome in CDI, which may have been underestimated. Further studies on the diagnostic applications and therapeutic potentials of these findings are warranted.</AbstractText>

Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage

Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population

Integrating Gut Microbiota and Host Immune Markers for Highly Accurate Diagnosis of Clostridioides Difficile Infection

Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection

Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection

Insight into Alteration of Gut Microbiota in Clostridium Difficile Infection and Asymptomatic C. Difficile Colonization

Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China

Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort

The Evaluation of Fecal Microbiota Transplantation Vs Vancomycin in a Clostridioides Difficile Infection Model.

The Role of Gut Fungi in Clostridioides Difficile Infection

Bacterial and Fungal Microbiota Changes Distinguish C. difficile Infection from Other Forms of Diarrhea: Results of a Prospective Inpatient Study

Characterization and dynamics of intestinal microbiota in patients with Clostridioides difficile colonization and infection

Clostridioides difficile infection is associated with differences in transcriptionally active microbial communities

Molecular Characterization and Antibiotic Resistance of Clostridioides Difficile in Patients with Inflammatory Bowel Disease from Two Hospitals in China

Molecular Characterization and Antibiotic Profile of Clostridium Difficile Isolated from Bacteremia

Fecal fungal microbiota alterations associated with clinical phenotypes in Crohn’s disease in southwest China

Bacteria Co-Colonizing with Clostridioides Difficile in Two Asymptomatic Patients

Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea

Host origin of microbiota drives functional recovery and Clostridioides difficile clearance in mice

Gut Microbiota Composition Associated with Clostridium Difficile-Positive Diarrhea and C. Difficile Type in ICU Patients

Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation